© 2000 by European Society of Cardiology
Role of the serotonergic system in the genesis of vasovagal syncope
1Division of Cardiology, Ospedale Civile Cento, (Fe), Italy; 2Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara Ferrara, Italy; 3Division of Internal Medicine, Arcispedale S. Anna Ferrara, Italy
AIMS: The hypotensive reflex responsible for vasovagal syncope appears related to a reduction in sympathetic neural outflow. Several animal studies suggest that serotonin may play a role in the genesis of this reflex, through inhibition of sympathetic activity. However, the role of the serotonergic system is unknown in humans. The purpose of the study was to investigate the role of the serotonergic system in the genesis of vasovagal syncope by means of the level of platelet and plasma serotonin, as well as plasma catecholamines, during tilt-induced syncope.
METHODS AND RESULTS: Fifteen patients (age 34±16 years) with vasovagal syncope underwent a head-up tilt test (HUT, 60°, 45 min). If syncope did not develop, 300 µg nitroglycerin was administered sublingually and patients continued to be tilted for a further 20 min. Blood samples were obtained in the supine position, and then after 3, 10, 15, 30, 45, 48 and 65 min of HUT. If syncope developed, blood samples were obtained at the beginning of the prodrome, during syncope and after the recovery of consciousness. Platelet and plasma serotonin and plasma catecholamines were measured using high-pressure liquid chromatography with electrochemical detection. Ten patients developed syncope during the unmedicated HUT and four after nitroglycerin. In these patients plasma adrenaline significantly increased from the last programmed sample before the prodrome to its beginning and showed a further increase during loss of consciousness, whereas plasma noradrenaline did not increase, as an expression of inhibition of sympathetic neural outflow. In the patients experiencing syncope, both platelet and plasma serotonin showed no significant change after tilt-up, at the beginning of prodrome, during syncope and after recovery of consciousness.
CONCLUSION: These results do not suggest that the serotonergic system plays a role in the pathophysiology of vasovagal syncope.
Key Words: Vasovagal syncope, serotonin, catecholamines, tilt test
Correspondence: Dr Paolo Alboni, Division of Cardiology, Ospedale Civile, 44042 Cento (FE)—Italy.
[1] Wallin BG and Sundlöf G. Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 1982; 6: 287–291.[CrossRef][Web of Science][Medline]
[2] Sanders JS and Ferguson DW. Profound sympathoinhibition complicating hypovolemia in humans. Ann Intern Med 1989; 111: 439–441.
[3] Morillo CA and Villar JC. Current insight on the pathophysiology of vasovagal syncope: what have we learned? In Raviele A (Ed.). Cardiac Arrhythmias 1997 1997; Milano Springer pp. 377–383.
[4] Antonaccio MJ and Robson RD. Centrally-mediated cardiovascular effects of 5-hydroxytryptophan in MAO-inhibited dogs: modification by autonomic antagonists. Arch Intern Pharmacol 1975; 213: 200–210.
[5] Baum T and Shropshire AT. Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan in centrall administered 5-hydroxytryptamine. Neuropharmacol 1975; 14: 227–233.[Medline]
[6] Tadepelli A, Mills E, Schanberg S. Central depressor of carotid baroreceptor pressor response, arterial pressure and heart rate by 5-hydroxytryptophan: influence of the supramolecular areas of the brain. J Pharmacol Exper Ther 1977; 202: 310–319.
[7] Elam RF, Bergman F, Feverstein G. The use of antiserotonergic agents for the treatment of acute hemorrhagic shock in cats. Eur J Pharmacol 1985; 107: 275–278.[CrossRef][Web of Science][Medline]
[8] Morgan DA, Thoren P, Wilczynski EA, Victor RG, Mark AL. Serotonergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats. Am J Physiol 1988; 255: 496–502.
[9] Strasberg B, Jagie A, Erdmann S. Carotid sinus hypersensitivity and the carotid sinus syndrome. Prog Cardiovasc Dis 1989; 5: 379–385.
[10] Evans RG, Kapoor V, Ludbrook J. A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits? J Cardiovasc Pharmacol 1992; 19: 1009–1017.[CrossRef][Web of Science][Medline]
[11] Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993; 328: 1117–1119.
[12] Houston DS and Vanhoutte PM. Serotonin and the vascular system. Role in health and disease, implications for therapy. Drugs 1986; 31: 149–163.[Web of Science][Medline]
[13] Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E. Tritiated impramine binding sites are decreased in plateletes of untreated depressed patients. Science 1980; 11: 303–305.
[14] Verbeuren TJ. Synthesis, storage, release and metabolism of 5-hydroxytryptamine in peripheral tissue. In Fozard J (Ed.). The peripheral actions of 5-hydroxytryptamine 1989; Oxford Oxford University Press pp. 1–25.
[15] Celada P, Sarrias MJ, Artigas F. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm Suppl 1990; 32: 149–154.[Medline]
[16] Sleight AJ, Marsden CA, Martin KF, Palfreyman MG. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan. Br J Pharmacol 1988; 93: 303–310.[Web of Science][Medline]
[17] Yan D, Urano T, Pietraszek MH. Correlation between serotonergic measures in cerebrospinal fluid and blood of subhuman primates. Life Sciences 1993; 52: 745–749.[CrossRef][Web of Science][Medline]
[18] Sarrias MJ, Cabré P, Martinez E, Artigas F. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem 1990; 54: 783–786.[Web of Science][Medline]
[19] Sarrias MJ, Artigas F, Martinez E. Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry 1987; 22: 1429–1438.[CrossRef][Web of Science][Medline]
[20] Cook EH, Leventhal BL, Heller W, Metz J, Wainwright M, Fredman DX. Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 1990; 2: 268–274.
[21] Marazziti D, Palego L, Silvestri S. Platelet abnormalities in aggressive subjects with mental deficiency. J Psychiatry Neurosci 1996; 21: 109–113.[Web of Science][Medline]
[22] Alboni P, Menozzi C, Brignole M. An abnormal neural reflex plays a role in causing syncope in sinus bradycardia. J Am Coll Cardiol 1993; 22: 1130–1134.[Abstract]
[23] Kenny RA, Bayliss J, Ingram A, Sutton R. Head up tilt: a useful test for investigating unexplained syncope. Lancet 1986; 1: 1352–1354.[CrossRef][Web of Science][Medline]
[24] Raviele A, Menozzi C, Brignole M. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995; 76: 267–272.[CrossRef][Web of Science][Medline]
[25] Balaji S, Oslizlok PC, Allen MC, McKay CA, Gillette PC. Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 1994; 23: 779–785.[Abstract]
[26] Sra JS, Murthy V, Natale A. Circulatory and catecholamine changes in neurocardiogenic (vasovagal) syncope. Am J Cardiol 1994; 73: 33–37.[CrossRef][Web of Science][Medline]
[27] Wallbridge DR, MacIntyre HE, Gray CE. Increase in plasma ß endorphins precedes vasodepressor syncope. Br Heart J 1994; 71: 446–448.
[28] Wallbridge DR, MacIntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM. Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J 1996; 17: 1729–1736.
[29] Fuller RW. Neural functions of serotonin. Scientific American Sci Med 1995; 4: 48–57.
[30] Theodorakis GN, Markianos M, Livanis EG, Zarvalis E, Flevari P, Kremastinos DT. Central serotonergic responsiveness in neurocardiogenic syncope. A clomipramine test challenge. Circulation 1998; 98: 2724–2730.
[31] Matzen S, Secher NH, Knigge U. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans. Acta Physiol Scand 1993; 149: 163–176.[Web of Science][Medline]
[32] Di Giordano E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydorcloride, a selective serotonin reuptake inhibitor on refractory vasovagal syncope: a randomized double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 33: 1227–1230.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Alboni, M. Brignole, and E. C. degli Uberti Is vasovagal syncope a disease? Europace, February 1, 2007; 9(2): 83 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Guzman, R. G. Garcia, R. Dillenburg, F. S. Sieger, P. Lopez-Jaramillo, and C. A. Morillo Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope. Europace, April 1, 2006; 8(4): 306 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bechir, C. Binggeli, R. Corti, R. Chenevard, L. Spieker, F. Ruschitzka, T. F. Luscher, and G. Noll Dysfunctional Baroreflex Regulation of Sympathetic Nerve Activity in Patients With Vasovagal Syncope Circulation, April 1, 2003; 107(12): 1620 - 1625. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||